Human cytomegalovirus pUL29/28 and pUL38 repression of p53-regulated p21CIP1 and caspase 1 promoters during infection.
about
Quantitative temporal viromics: an approach to investigate host-pathogen interactionPUL21a-Cyclin A2 interaction is required to protect human cytomegalovirus-infected cells from the deleterious consequences of mitotic entry.Cis and trans acting factors involved in human cytomegalovirus experimental and natural latent infection of CD14 (+) monocytes and CD34 (+) cells.Interaction network of proteins associated with human cytomegalovirus IE2-p86 protein during infection: a proteomic analysis.DNA repair mechanisms and human cytomegalovirus (HCMV) infection.Tuberous Sclerosis Complex Protein 2-Independent Activation of mTORC1 by Human Cytomegalovirus pUL38.Antagonistic Relationship between Human Cytomegalovirus pUL27 and pUL97 Activities during Infection.Broad and potent antiviral activity of the NAE inhibitor MLN4924.Human cytomegalovirus pUL97 regulates the viral major immediate early promoter by phosphorylation-mediated disruption of histone deacetylase 1 binding.Human cytomegalovirus pUL37x1-induced calcium flux activates PKCα, inducing altered cell shape and accumulation of cytoplasmic vesicles.Functional annotation of human cytomegalovirus gene products: an update.Proteomic identification of nuclear processes manipulated by cytomegalovirus early during infection.The Putative Role of Viruses, Bacteria, and Chronic Fungal Biotoxin Exposure in the Genesis of Intractable Fatigue Accompanied by Cognitive and Physical Disability.Cytomegalovirus Late Protein pUL31 Alters Pre-rRNA Expression and Nuclear Organization during Infection.Human Cytomegalovirus nuclear egress and secondary envelopment are negatively affected in the absence of cellular p53.Fatty acid elongase 7 catalyzes lipidome remodeling essential for human cytomegalovirus replication.
P2860
Q33722378-C43A7EAB-6CEF-4A7C-93BB-C4590FD6294DQ34506903-908CA1BF-2B41-4F82-BA60-FC84281D5AB4Q34743747-425EBF8B-D611-45F6-A3AE-673398631C1BQ35072528-3E489A67-DC5E-4642-A188-6CB880C99F31Q35598400-6176ADF4-E029-438E-8F76-AD562AC9F437Q35861166-5523A1AE-FE0F-44D8-8598-FB683736504DQ36086320-AF809C5B-83CD-4176-AA45-E14A9783E9A4Q36524801-3D042D79-B5FE-4B42-BA3E-EF5BE1A2354CQ36978826-D0A777D6-6BF8-478D-B13C-E393F0724078Q37674586-5096131A-498E-419A-9FD4-4E147DAECAE8Q38218104-A9BA2763-B202-4DDD-9820-C390855618CCQ38415133-7291AB78-4413-4F7A-A6BB-244032B79F4BQ38529622-8C758A04-8608-45DE-96B6-7DDD3394DAFFQ38698697-AE68A31B-1CF6-4741-9B5D-EA1CD41438A4Q38753357-538028EE-2754-4ABB-8E84-D5AB83EF1467Q38904514-167BDDF9-6B14-4539-95B8-7613FF31C0CC
P2860
Human cytomegalovirus pUL29/28 and pUL38 repression of p53-regulated p21CIP1 and caspase 1 promoters during infection.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Human cytomegalovirus pUL29/28 ...... 1 promoters during infection.
@ast
Human cytomegalovirus pUL29/28 ...... 1 promoters during infection.
@en
type
label
Human cytomegalovirus pUL29/28 ...... 1 promoters during infection.
@ast
Human cytomegalovirus pUL29/28 ...... 1 promoters during infection.
@en
prefLabel
Human cytomegalovirus pUL29/28 ...... 1 promoters during infection.
@ast
Human cytomegalovirus pUL29/28 ...... 1 promoters during infection.
@en
P2093
P2860
P356
P1433
P1476
Human cytomegalovirus pUL29/28 ...... 1 promoters during infection.
@en
P2093
Brian D Halligan
John P Savaryn
Justin M Reitsma
Scott S Terhune
Tarin M Bigley
Zhikang Qian
P2860
P304
P356
10.1128/JVI.01926-12
P407
P577
2012-12-12T00:00:00Z